Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis

Clinical trial NCT03478605 · UNKNOWN

Trial details

NCT number: NCT03478605
Sponsor: Blokhin's Russian Cancer Research Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Emesis Vomiting Nausea Post Chemotherapy Nausea Chemotherapy-induced Nausea and Vomiting

Start date: 2018-05-25
Primary completion: 2019-05-25
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.